Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
11/12/1998 | CA2288640A1 Enzymatic nucleic acids: synthesis, selection and use |
11/12/1998 | CA2288639A1 Aplidine as an l-type calcium channel enhancer |
11/12/1998 | CA2288435A1 Recombinant lactoferrin, methods of production from plants and uses |
11/12/1998 | CA2288232A1 Immunotoxins directed against malignant cells |
11/12/1998 | CA2288017A1 Methods for eosinophil depletion and compositions therefor |
11/12/1998 | CA2287569A1 Serine protease inhibitors |
11/12/1998 | CA2259635A1 Hmgi proteins in tumors and obesity |
11/11/1998 | EP0877085A1 OspA protein of borrelia burgdorferi subgroups, encoding genes and vaccines |
11/11/1998 | EP0877083A1 A novel human G-protein coupled receptor (HCEPT09) |
11/11/1998 | EP0877032A1 Specific antibodies for use in preparation of pharmaceutical compositions useful in the prevention or treatment of gastritis, gastric ulcers and duodenal ulcers |
11/11/1998 | EP0877031A1 TGF-Beta1 derived peptides mimicking the activity of transforming growth factor-Beta1 |
11/11/1998 | EP0877030A2 EPO primary response gene 1,(EPRG1) |
11/11/1998 | EP0876610A1 A method and use of polypeptide in sperm-egg binding to enhance or decrease fertility |
11/11/1998 | EP0876512A1 Methods for identifying inhibitors of rna viruses |
11/11/1998 | EP0876498A1 Mixture of recombinant vaccinia vectors as polygeur vaccines for hiv |
11/11/1998 | EP0876487A1 Mammalian cx 3?c chemokine genes |
11/11/1998 | EP0876486A2 Murine monoclonal anti-idiotype antibody 11d10 an methods of use thereof |
11/11/1998 | EP0876485A2 NOVEL CREBa ISOFORM |
11/11/1998 | EP0876484A1 Recombinant expression of proteins from secretory cell lines |
11/11/1998 | EP0876483A1 Nucleic acids and proteins related to alzheimer's disease, and uses therefor |
11/11/1998 | EP0876482A1 Il-13 receptor polypeptide |
11/11/1998 | EP0876478A1 Monoclonal antibody to herpes simplex virus and cell line producing same |
11/11/1998 | EP0876402A1 Growth hormone secretagogue receptor family |
11/11/1998 | EP0876400A2 Vertebrate fringe proteins |
11/11/1998 | EP0876399A1 Peptides and uses thereof for therapy of celiac diseases |
11/11/1998 | EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX |
11/11/1998 | EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME |
11/11/1998 | EP0876387A1 Method to improve the biological and antiviral activity of protease inhibitors |
11/11/1998 | EP0876371A1 Reverse-turn mimetics and methods relating thereto |
11/11/1998 | EP0876365A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors |
11/11/1998 | EP0876337A2 New lh-rh antagonists with improved effectiveness |
11/11/1998 | EP0876166A1 Use of injectable or implantable biomaterials for filling or blocking lumens and voids of the body |
11/11/1998 | EP0876158A1 Novel medical use of an ace-inhibitor for treatment of dyspeptic symptoms |
11/11/1998 | EP0876157A1 Methods and compositions for passive immunotherapy |
11/11/1998 | EP0876155A1 Highly concentrated, lyophilized, and liquid factor ix formulations |
11/11/1998 | EP0876154A1 Using serine-proteases for acne and inflamed comedones |
11/11/1998 | EP0876153A2 Medical use of proteases |
11/11/1998 | EP0876152A1 Novel administration of thrombopoietin |
11/11/1998 | EP0876146A1 Nucleoside analogs in combination therapy of herpes simplex infections |
11/11/1998 | EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration |
11/11/1998 | EP0876139A1 Medicament forms constituted in situ for releasing enzymes into wounds |
11/11/1998 | EP0831908A4 Methods of increasing cd4+ cell numbers in hiv-infected individuals |
11/11/1998 | EP0766570A4 Methods for treating respiratory disease |
11/11/1998 | EP0744940B1 Drugs, vaccines and hormones in polylactide coated microspheres |
11/11/1998 | EP0630412B1 Methods to profile and treat abnormal cells |
11/11/1998 | EP0598011B1 Ecdysteroid dependent regulation of genes in mammalian cells |
11/11/1998 | EP0586381B1 Improved blood substitute |
11/11/1998 | EP0579826B1 Carbapenems containing a carboxy substituted phenyl group, processes for their preparation, intermediates and use as antibiotics |
11/11/1998 | CN1198778A Aspergillus arabinofuranosidase |
11/11/1998 | CN1198776A Novel DNAS and process for producing proteins by using the same |
11/11/1998 | CN1198775A Recombinant c-proteinase and processes, methods and uses thereof |
11/11/1998 | CN1198748A Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
11/11/1998 | CN1198747A Thio-substituted peptides as inhibitors for metalloproteinases and tnfliberation |
11/11/1998 | CN1198675A Medicine comprising HGF gene |
11/11/1998 | CN1198673A Pharmaceutical angiostatic dipeptide compositions and methods of use thereof |
11/11/1998 | CN1198669A Use of aminoadamantane compound as immunoregulators |
11/11/1998 | CN1198667A Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
11/11/1998 | CN1040648C Process for preparing 1-deamino-8-D-arginine vasopressin |
11/10/1998 | US5834599 Monoclonal antibodies which bind to an epitope of gp120, conjugated to a cytotoxic agent, anti-viral agent, or an agent to facilitate passage through the blood-brain barrier; inhibit t-cell infection, syncytium formation; immunotoxins |
11/10/1998 | US5834597 Treating disorders requiring immune suppression with fewer side effects |
11/10/1998 | US5834596 Process for purifying ApoA or ApoE |
11/10/1998 | US5834594 Polyethylene-protein conjugates |
11/10/1998 | US5834593 Genetic engineering of prion protein |
11/10/1998 | US5834592 Leishmania antigens for use in the therapy and diagnosis of Leishmaniasis |
11/10/1998 | US5834590 Ingap protein involved in pancreatic islet neogenesis |
11/10/1998 | US5834589 Chimeric viral receptor polypeptides |
11/10/1998 | US5834587 G-protein coupled receptor, HLTEX 11 |
11/10/1998 | US5834586 Dehydrodidemnin B |
11/10/1998 | US5834508 Ketone derivatives |
11/10/1998 | US5834487 Inhibition of 26S and 20S proteasome by indanones |
11/10/1998 | US5834474 Enantiomerically pure B--D--dioxolane nucleosides with selective anti-hepatitus B virus activity |
11/10/1998 | US5834441 Introducing a genetic sequence into a host cell |
11/10/1998 | US5834440 Administering to human muscle cell an effective amount of dna to favor transcription of the dna to produce ribozyme |
11/10/1998 | US5834435 Administering n-acetyl-d-glucosaminyl-n-acetyl-muramyl-l-alanyl-d-isoglutami ne |
11/10/1998 | US5834434 Inhibitors of farnesyltransferase |
11/10/1998 | US5834432 Use of angiotensin II Type 2 receptor agonists in tissue repair |
11/10/1998 | US5834431 Oligopeptide as bradykinin antagonist, antiinflammatory agent; highly potent, stability; selective b1 receptor antagonists |
11/10/1998 | US5834430 Potentiation of antibiotics |
11/10/1998 | US5834429 Inhibiting binding of a hiv antigen to receptors on cells of mammals |
11/10/1998 | US5834428 Glucagon-like peptide-2 and its therapeutic use |
11/10/1998 | US5834427 Novel amino acid sequence wherein the 25th arginine is replaced by cysteine, so that a dimer is formed by a disulfide bond; food or beverage additive for enhancing calcium or iron absorption |
11/10/1998 | US5834425 Composite of lectin and epidermal growth factor domains, treatment of pathological leukocyte mediated inflammation |
11/10/1998 | US5834424 Use of lactoferrin for therapy of acute of chronic infectious diseases by the intracellular gram-positive pathogens streptococcus pyogenes and staphylococcus aureus |
11/10/1998 | US5834422 Comprising insulin analog, protamine, zinc, and a phenol; forming stable suspension |
11/10/1998 | US5834420 Fibrinogen concentrate obtained from blood plasma, process and plant for its preparation |
11/10/1998 | US5834419 Chemokine binding protein and methods of use therefor |
11/10/1998 | US5834309 Altering and/or regulating programmed cell death, genetic engineering, codes, expression vectors |
11/10/1998 | US5834306 Tissue specific hypoxia regulated therapeutic constructs |
11/10/1998 | US5834298 Antitumor agents |
11/10/1998 | US5834290 Skin disorders such as acne, xeroderma, hyperkeratotic conditions, callosities and keratosis pilaris; ichthyoses, psoriasis and eczemas; autoimmune pemphigus, acatholytic diseases, familiar pemphigus and darier's disease |
11/10/1998 | US5834287 Culture product enzgyme obtained from genetic expressed microorganism; the enzyme can release trehalose from non-reducing oligo- or poly-saccharides having a trehalose structure as an end unit |
11/10/1998 | US5834283 Isolated, purified active enzyme encoded by a recombinant dna; screening for anticholesterol agents; medical diagnosis |
11/10/1998 | US5834278 Bacterial peptide methionine sulfoxide reductase an adhesion-associated protein, and antibiotic therapies based thereon |
11/10/1998 | US5834276 Asparaginyl TRNA synthetase polynucleotides of streptococcus |
11/10/1998 | US5834274 Free radical photopolymerizable |
11/10/1998 | US5834266 Regulated apoptosis |
11/10/1998 | US5834250 Replacement of segment of polypeptide; calibration |
11/10/1998 | US5834248 Treatment and diagnosis of cardiovascular disease |
11/10/1998 | US5834245 Platelet-derived growth factor receptor beta-like tumor suppressor (prlts), from the short arm of human chromosome 8; distinguishing tumor cells from normal cells; host cells transformed with expression vectors for its production |
11/10/1998 | US5834244 Factor VIIa inhibitors from Kunitz domain proteins |